🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
This is extension of the V102\_16 study (NCT02140762). V102\_16E1 is design...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02285777
Treatments Being Tested
The purpose of this study was to assess immunogenicity and safety of MenABC...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-25
Trial ID
NCT04707391
Treatments Being Tested
The main purposes for conducting the study are firstly to assess immunologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-21
Trial ID
NCT02212457
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-11-29
Trial ID
NCT05082285
This study will evaluate the safety and immunogenicity of combination vacci...
Status
Completed
Location
Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615
Start Date
2011-08
Trial ID
NCT01272180
Treatments Being Tested
Evaluate the effectiveness of 2 doses of MenABCWY vaccine in adolescents co...
Status
Completed
Location
Accelovance, Inc
Start Date
2014-05
Trial ID
NCT02140762
The purpose of this study is to compare the persistence of 2 or 3 doses of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-11-15
Trial ID
NCT02946385
Treatments Being Tested
The purpose of this study was to evaluate the effectiveness of 2 doses or 3...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04502693